The civic record
Read. Follow. Verify.California SB 950 requires health plans to cover FDA-approved Alzheimer's treatments without step therapy
Record date · August 30, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
Starting January 1, 2027, health insurance plans in California must cover all FDA-approved medications and treatments for Alzheimer's disease and memory-related conditions when deemed medically necessary by a provider. The bill also prohibits insurers from requiring ''—a process where patients must try cheaper drugs first—before authorizing these treatments.
This change ensures that patients with Alzheimer's and memory disorders can access FDA-approved treatments immediately upon provider recommendation, removing insurance-imposed delays or requirements to fail on other medications first.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Patients with Alzheimer's disease
Patients gain access to FDA-approved treatments without the requirement to undergo step therapy protocols.
Health care service plans
Plans must update coverage policies to include all FDA-approved Alzheimer's treatments and remove step therapy requirements.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Does this bill apply to all health insurance plans?
What is 'step therapy' and why is it being prohibited?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently filed. The next step in the legislative lifecycle is Committee.
Version history & redline
3 versions on fileOfficial version history is partial: 3 linked texts are unavailable or incomplete. Source links remain available below.
The text diff for this stage has not been computed yet.
pdf extract failed: Invalid PDF structure.
Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Elimination of Step Therapy for Alzheimer's
The bill represents a targeted legislative effort to remove cost-containment barriers (step therapy) specifically for Alzheimer's and memory-related treatments.
Connected Entities
Sources
openstates.org
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools